Non-targeted screening for novel psychoactive substances among agitated emergency department patients
Derrick Lung(University of California, San Francisco), Roy Gerona(University of California, San Francisco), Nathan Wilson(University of California, San Francisco), Clémence Lacroix(Inserm), Francois-Thibaut Chatenet(Université Savoie Mont Blanc)
Cited by 42
Related Papers
French consensus regarding precautions during tracheostomy and post-tracheostomy care in the context of COVID-19 pandemic
|European Annals of Otorhinolaryngology Head and Neck Diseases|2020|76
Serious central nervous system side effects of cephalosporins: A national analysis of serious reports registered in the French Pharmacovigilance Database
|Journal of the Neurological Sciences|2019|60
Artificial Intelligence for Unstructured Healthcare Data: Application to Coding of Patient Reporting of Adverse Drug Reactions
|Clinical Pharmacology & Therapeutics|2021|48
Cannabis for the treatment of amyotrophic lateral sclerosis: What is the patients’ view?
|Revue Neurologique|2023|32
Serious Neurological Adverse Events of Ceftriaxone
|Antibiotics|2021|29